Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Proteins play a crucial role in health and disease and comprise the majority of disease biomarkers and drug targets. Mass spectrometry (MS) enables proteome-wide identification and quantitation of proteins with high specificity, precision, and unmatched specificity in virtually any type of sample, from archeological specimens to human tissue biopsies.
MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries. This new partnership will provide a complete solution for quantitative protein and metabolite analysis.
MONTREAL & BOULDER, Colo.--(BUSINESS WIRE)--Jan 28, 2019--MRM Proteomics Inc. and Biodesix® have inked a partnership to create novel assays to answer critical clinical questions within the lung cancer continuum of care. Under terms of the deal, MRM Proteomics will grant Biodesix rights to utilize its proprietary iMALDI technologies to further advance its blood-based lung cancer diagnostics.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
